Genes y Fenotipos de Síndromes Parkinsonianos: validación funcional de hallazgos genéticos.
Dades bàsiques
- Protocol:
- ParkGenPhen
- EURDRACT:
- NCT:
- Centre:
- HOSPITAL UNIVERSITARI I POLITÈCNIC LA FE
- Any inici:
- 2024
- Any de finalització:
Documents
- No hi ha documents
Participants
Grups d'Investigació
Finançadors - Promotors
JANET HOENICKA
Resultats de l'Assaig Clínic
Artificial intelligence for identification of candidates for device-aided therapy in Parkinson's disease: DELIST-PD study.
Freire-Alvarez, Eric; (...); Escamilla-Sevilla, Francisco
Article. 10.1016/j.compbiomed.2024.109504. 2024
Effectiveness and safety of levodopa-entacapone-carbidopa infusion in Parkinson disease: A real-world data study.
Santos-García D; (...); Mata M
Article. 10.1111/ene.16535. 2024
MRgFUS subthalamotomy in Parkinson's disease: an approach aimed at minimizing Lesion Volume
Campins-Romeu, Marina; (...); Martinez-Torres, Irene
Article. 10.1038/s41531-024-00843-7. 2024
MRgFUS subthalamotomy in Parkinson's disease: an approach aimed at minimizing Lesion Volume (vol 10, 230, 2024)
Campins-Romeu, Marina; (...); Martinez-Torres, Irene
Correction. 10.1038/s41531-025-00871-x. 2025
STUB1 Mutations as Possible Genetic Modifiers in Spinocerebellar Ataxia Type 8.
Baviera-Munoz, Raquel; (...); Aller, Elena
Article. 10.1002/mds.29910. 2024
Use of the MNCD Classification to Monitor Clinical Stage and Response to Levodopa-Entacapone-Carbidopa Intestinal Gel Infusion in Advanced Parkinson's Disease
Santos-Garcia, Diego; (...); Alvarez-Santullano, Marina Mata
Article. 10.3390/brainsci14121244. 2024